Common pain drug tested as secret weapon against tough colon cancer
NCT ID NCT05212012
Summary
This early-stage trial is testing whether adding the pain medication methadone to a standard chemotherapy regimen (mFOLFOX6) can help control advanced colorectal cancer that has stopped responding to other treatments. The study first aims to find a safe dose of the combination, then will compare tumor control rates at 12 weeks between patients receiving the methadone-chemo combo versus chemo alone. It involves a small group of patients whose cancer has progressed despite trying all standard therapies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMO-REFRACTORY COLORECTAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stauferklinikum Schwäbisch Gmünd
Mutlangen, 73557, Germany
-
Universitätsklinikum Hamburg Eppendorf - II. Med.
Hamburg, 20246, Germany
-
Universitätsklinikum Ulm - Innere Med. I
Ulm, 89081, Germany
Conditions
Explore the condition pages connected to this study.